144 Casting aspersions on Aspergillus – a comparison of clinical disease markers and therapy in patients with and without ABPA by Spencer-Clegg, E, Sapina-Vivo, R, Walshaw, M.J

Get full text

185 Doxycycline vs. chloramphenicol for use in exacerbations of CF by Taylor, A, Frost, F, Ledson, M.J, Spencer-Clegg, E, Sapina-Vivo, R, Walshaw, M.J

Get full text

187 Long-term continuous inhaled aztreonam (Cayston) BD by Frost, F, Sapina-Vivo, R, Nazareth, D, Greenwood, J, Ledson, M.J, Walshaw, M.J

Get full text

120 Continuous long term Cayston® : BD or not BD? by Jackson, M, Whitty, C, Greener, T, Sapina-Vivo, R, Walshaw, M.J

Get full text

167 Prucalopride use in patients with cystic fibrosis by Taylor, A, Walshaw, M.J, Sapina-Vivo, R, Cullen, D, Spencer-Clegg, E

Get full text

ePS06.3 Does Cayston® provide long term stability within cystic fibrosis in clinical practice? by Jackson, M, Whitty, C, Greener, T, Sapina-Vivo, R, Martin, W

Get full text

38 Cayston® in clinical practice – experiences from a UK adult CF unit by Lloyd, E.A, Sapina-Vivo, R, Jackson, M, Spencer-Clegg, E, Walshaw, M, Whitty, C

Get full text

40 Experience with Colobreathe® in a large adult cystic fibrosis unit by Sapina-Vivo, R, Lloyd, E.A, Mujtaba, H, Spencer-Clegg, E, Walshaw, M

Get full text

308 Assessing medication adherence in adult CF patients: involvement of the community by Sapina-Vivo, R, Ledson, M, Walshaw, M

Get full text

WS10.3 Adherence with ivacaftor in cystic fibrosis patients with the G551D mutation by Fox, J, Jones, G.H, Sapina-Vivo, R, Phitidis, E, Ledson, M, Walshaw, M, Greenwood, J

Get full text

65 The effectiveness of nebulised tobramycin over a 3 year period by Nazareth, D, Sapina-Vivo, R, Gallagher, J, Kazmi, S.M.H, Greenwood, J, Ledson, M.J, Walshaw, M.J

Get full text